Basics |
Company: |
Emergent Biosolutions, Inc. |
IPO Date: |
December 1, 2006 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$541.84M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.59 | 2.25%
|
Avg Daily Range (30 D): |
$0.24 | 2.46%
|
Avg Daily Range (90 D): |
$0.31 | 3.29%
|
Institutional Daily Volume |
Avg Daily Volume: |
.52M |
Avg Daily Volume (30 D): |
.8M |
Avg Daily Volume (90 D): |
1.08M |
Trade Size |
Avg Trade Size (Sh.): |
112 |
Avg Trade Size (Sh.) (30 D): |
95 |
Avg Trade Size (Sh.) (90 D): |
109 |
Institutional Trades |
Total Inst.Trades: |
4,774 |
Avg Inst. Trade: |
$2.56M |
Avg Inst. Trade (30 D): |
$1.25M |
Avg Inst. Trade (90 D): |
$1.13M |
Avg Inst. Trade Volume: |
.08M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$3.35M |
Avg Closing Trade (30 D): |
$1.2M |
Avg Closing Trade (90 D): |
$1.11M |
Avg Closing Volume: |
105.11K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-3.93
|
$2.16
|
$-5.38
|
Diluted EPS
|
$-4.03
|
$2.06
|
$-5.38
|
Revenue
|
$ 1.13B
|
$ 293.8M
|
$ 254.7M
|
Gross Profit
|
$ 345.8M
|
$ 161.2M
|
$ -48M
|
Net Income / Loss
|
$ -208.8M
|
$ 114.8M
|
$ -283.1M
|
Operating Income / Loss
|
$ -143M
|
$ 64.5M
|
$ -203.5M
|
Cost of Revenue
|
$ 748.4M
|
$ 122.6M
|
$ 296.1M
|
Net Cash Flow
|
$ 68.6M
|
$ 85.4M
|
$ -8M
|
PE Ratio
|
|
|
|
|